ArticlePaediatric drugs2021

Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of Four Randomized Clinical Trials.

Stephen V Faraone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.